<DOC>
	<DOC>NCT01948934</DOC>
	<brief_summary>The purpose of this study is to determine the safety of use of a new therapeutic strategy for the treatment of patients with large wounds</brief_summary>
	<brief_title>Clinic Trial in Phase 1 Using Amniotic Membrane for the Skin Replacement in Big Wounds</brief_title>
	<detailed_description>Amniotic membrane (AM) is a useful tissue as a biological dressing with numerous advantages it has a very similar structure to the skin and his biological and immunological properties.</detailed_description>
	<mesh_term>Wounds and Injuries</mesh_term>
	<criteria>Acute wounds in granulation phase with a minimum surface of 100cm2 â‰¥ 18 years signing informed consent form guarantee adherence to protocol chronic arterial insufficiency pregnant patients, lactating women or fertile adults that they don`t use an effective contraceptive method involved in other assay previous disease; kidney, heart, hepatic, systemic or immune inability to understand informed consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Skin</keyword>
	<keyword>Injury</keyword>
	<keyword>Membrane amniotic</keyword>
	<keyword>Wound</keyword>
</DOC>